Current Assets 更改
Acadia Pharmaceuticals USD 870.94M 67.38M 2025-03
Agios Pharmaceuticals USD 968.62M 3.02M 2025-03
Alnylam Pharmaceuticals USD 3.64B 375.44M 2025-06
Amgen USD 26.93B 2.1B 2025-03
Biogen USD 7.97B 341.7M 2025-06
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Eli Lilly USD 41.26B 8.52B 2025-03
Exelixis USD 1.18B 215.74M 2025-07
Gilead Sciences USD 19.17B 4.39B 2024-12
Incyte USD 3.64B 411.91M 2025-06
Ionis Pharmaceuticals USD 2.58B 158.22M 2025-06
MacroGenics USD 217.49M 4.71M 2024-12
Merck USD 35.5B 3.28B 2025-03
Moderna USD 6.77B 1.33B 2025-03
Neurocrine Biosciences USD 1.75B 111M 2025-06
Novartis USD 25.94B 831M 2025-06
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 45.86B 4.5B 2025-03
PTC Therapeutics USD 2.32B 950.88M 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Sarepta Therapeutics USD 2.43B 640.93M 2025-03
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12


Incyte 流动资产 - 当前值,历史数据,预测,统计,图表和经济日历 - Aug 2025.